2m 2m 2m 2m 2m 2m 2m
Vireo Growth (VREOF)
OTC
$8.51-$0.40 (-4.49%)
Price as of Oct 22, 2026- $438.6MMarket Cap
- -54.97%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Vireo Growth (VREOF)
$8.51-$0.40 (-4.49%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$8.36
$9.01
$8.51
1-Year Range
$0.36
$12.85
$8.51
Latest Close$8.51
Change
-$0.40 (-4.70%)
Volume19,134
Market Cap$438.6M
Shares Outstanding51.5M
P/E (TTM)-4.69
Diluted EPS (TTM)-$1.81
Enterprise Value$657.9M
Information as of 10/22/2026
Company Profile
Vireo Health International, Inc.
https://vireogrowth.com$438.6M
Market Cap
-$67.1M
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
207 South 9th Street, Minneapolis, MN, United States, 55402
612 999 1606Vireo Growth Inc. operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, Missouri, Nevada, New York, and Utah. It sells cannabis products through a network of retail dispensaries and distributors. The company was formerly known as Goodness Growth Holdings, Inc. and changed its name to Vireo Growth Inc. in July 2024. Vireo Growth Inc. was incorporated in 2004 and is headquartered in Minneapolis, Minnesota.
Key Executives
- John Michael Mazarakis
- James Tyson Macdonald
- Sean Michael Apfelbaum
- Amber H. Shimpa
- Kyle E. Kingsley
Current Ownership Distribution
- Other35.9M (93.95%)
- Insiders2.3M (6.05%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)